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Abstract 
BACKGROUND: Systemic Lupus Erythematosus (SLE) is an autoimmune disorder mediated by inflammatory 
cytokines. Decreasing vitamin D levels is a common feature in SLE patients. Vitamin D has the capacity in 
suppressing inflammatory cascade. Seluang fish (Rasbora spp.) contained a high level of vitamin D with the 
potential as a new therapeutic modality. 
AIM: This study aimed to assess the efficacy of Seluang fish oil against proinflammatory cytokines, vitamin D 
levels, and clinical conditions of SLE. 
METHODS: A randomised, double-blind, clinical trial study design was conducted. The subjects were 16 SLE 
subjects treated with 500uL Seluang fish oil capsules and 16 SLE subjects with placebo capsules. Measurement 
of vitamin D, IL-1, IL-6 and IL-17 levels were performed with ELISA. Clinical assessment of SLE was performed 
with MEX-SLEDAI. Bivariate analysis, T-test, was performed. Data were presented in the form of mean ± SD. 
RESULTS: The administration of Seluang fish oil was clinically able to show efficacy assessed by the MEX 
SLEDAI score. Significant results were also shown by increased vitamin D levels and reduced levels of IL-1, IL-6 
and IL-17, in Seluang fish oil group. 
CONCLUSION: Seluang fish oil possessed the efficacy of reducing the inflammatory response in SLE patients by 
increasing serum vitamin D levels. 
 
 
 
 
Introduction 
 
Systemic Lupus Erythematosus (SLE) is one 
of the threatening autoimmune diseases that impend 
global health. The prevalence of SLE in the Asia-
Pacific Region is 4.3-45.3 per 100,000 populations. 
Meanwhile, the prevalence of SLE in Indonesia is 
0.5%, and the prevalence is escalating from year to 
year. There are 16.000 new SLE cases in the United 
States. This shows the number of new SLE cases is 
very significant. The cases of SLE require solemn 
emphasis from the pathophysiological aspects to a 
comprehensive therapeutic approach [1]. 
SLE is a prototype of an autoimmune disorder 
characterised by antibody production towards 
components of the cell nucleus. The pathological 
conditions found in SLE patients are related to the 
inflammatory process, vasculitis, immune complex 
deposition and vasculopathy. The inflammatory 
process is the main pathological condition in SLE 
disorders [2]. SLE begins with the formation of 
antibodies against the cell components of the 
individual itself, and Anti-double Stranded DNA (ds-
DNA) is found in 95% of SLE cases.  
The presence of ds-DNA is triggered by an 
increase in the B cell population, due to a decrease in 
the production of T cells, triggered by the production 
of IL-2. Increased IL-2 will promote the activation of 
Th-17 cells to produce IL-17. This condition will 
activate the inflammatory cascade, which is mediated 
by interleukin-1 (IL-1), IL-6 and Tumor Necrosis 
Factor-Alpha (TNF-), which are responsible for the 
damage in various target organs and eventually will 
lead to target organ failure [3]. 
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Vitamin D is a steroid hormone playing a role 
in the regulation of cell growth, proliferation, apoptosis 
and regulation of the immune system. Vitamin D 
deficiency is one of the clinical conditions that further 
aggravate clinical SLE. Decreasing vitamin D levels is 
a common feature in SLE patients. Administration of 
immunosuppressant drugs (glucocorticoids) will 
trigger a decrease in vitamin D levels. Nevertheless 
the drug is the standard drug consumed by SLE 
patients. Vitamin D has the capacity in suppressing 
the immune response so that it will suppress 
inflammatory cascade [4]. Vitamin D supplementation 
was able to optimally demote clinical problems in SLE 
patients [5]. Therefore, vitamin D supplementation in 
SLE patients becomes strategic management. 
Exploration of the vitamin D source modality 
is a strategic step for SLE management. Seluang fish 
(Rasbora spp.) is an endemic freshwater fish in South 
Sumatra, Indonesia. Seluang fish is the first level 
consumer in its food chain. As a first level consumer, 
it is safe from the accumulation of heavy metal 
contamination commonly found in top consumer fish. 
It is rich in oil that lines up the fish body. Previous 
studies showed that Seluang fish oil contained vitamin 
D (cholecalciferol) in the amount of 2043.34 IU/mL [6]. 
With a massive vitamin D content, Seluang fish oil 
possesses the potential to be further investigated 
regarding its efficacy in SLE cases. 
This study aimed to assess the efficacy of 
Seluang fish oil against proinflammatory cytokines (IL-
1, IL-6, IL-17), serum Vitamin D levels, and MEX-
SLEDAI clinical scores in SLE patients. 
 
 
Material and Methods 
 
Subjects 
A randomised, double-blind, clinical trial study 
design was conducted. This study was conducted in 
the Rheumatology Outpatient Internal Medicine 
Department, Dr Moh. Hoesin General Hospital 
Palembang, South Sumatra, Indonesia. This study 
was by the Declaration of Helsinki of the World 
Medical Association and had received ethical approval 
by the Ethics Committee Faculty of Medicine, 
Universitas Sriwijaya, Dr Moh Hoesin General 
Hospital Palembang. Informed consent was done for 
all study subjects. The subjects of this study were 32 
patients who met the criteria of American College of 
Rheumatology (ACR) 1997 classification, consisting of 
16 SLE subjects who were treated with 500 uL 
Seluang fish oil capsules, one capsule per day, for 90 
days and 16 SLE subjects who received placebo 
capsules. Study subjects were between 15-50 years, 
with no comorbidities or severe clinical conditions. 
 
Measurement of proinflammatory 
cytokines and vitamin D levels 
Three ml blood was withdrawn from each 
study subject, which was then inserted into the EDTA 
tube, then centrifuged at a speed of 5000 rpm for 10 
minutes. The supernatant was obtained and stored at 
-20°C. Measurement of Vitamin D, IL-1, IL-6 and IL-17 
levels was performed with Enzyme-linked 
Immunosorbent Assay (ELISA) technique Cloud-
Clone (Cloud-Clone Corp., Texas, USA), by the work 
protocol issued by the manufacturer. 
 
Clinical assessment of SLE 
Clinical assessment of SLE was performed 
with the Systemic Lupus Erythematosus Disease 
Activity Index scoring system (SLEDAI) using data 
from medical records and laboratory findings. This 
scoring consisted of 24 items with a total score of 0-
105. 
Statistical analysis 
Data analysis was carried out using SPSS 
24.0 software (SPSS Inc., Chicago, USA). Data were 
presented in the form of mean ± SD. Bivariate 
analysis, T-test, was conducted to analyse mean 
differences between the treatment and control groups. 
Statistical significance was of p-value < 0.05. 
 
 
Results  
 
Table 1 exhibited that the clinical conditions of 
the study subjects between the treatment group and 
the control group were not statistically different. The 
subjects showed the equality of clinical conditions in 
SLE so that the possibility of bias in this study could 
be prevented. 
Table 1: Baseline Characteristics of Study Subjects 
Characteristics 
Treatment Placebo 
P-value 
Mean ± SD Mean ± SD 
Age (years) 30.31 ± 9.32 26.75 ± 8.96 0.227 * 
Duration of SLE (months) 18.63 ±13.54 21.09 ± 4.80 0.677* 
Haemoglobin (g/dL) 12.42 ± 1.89 11.69 ± 1.25 0.210* 
Leukocyte (x 10
3
) (/μL) 8.6 ± 3.28 8.69 ± 2.84 0.936* 
Platelet (x 10
3
) (/μL) 294.8 ± 56.34 330.81 ± 114.39 0.985* 
Blood sugar (mg/dL) 106.5 ± 33.08 105.38 ± 19.89 0.692* 
Ureum (mg/dL) 23.13 ± 7.81 25.5 ± 11.42 0.748* 
Creatinine (mg/dL) 0.693 ± 0.117 0.683 ± 0.286 0.126* 
SGOT (AST) (U/L) 20.31 ± 10.24 20.88 ± 7.35 0.416* 
SGPT (ALT) (U/L) 22.38 ± 15.66 22.00 ± 9.68 0.521* 
Calcium (mg/dL) 1.14 ± 0.08 1.17 ± 0.06 0.383* 
dsDNA (ng/mL) 434.4 ± 55.46 423.0 ± 52.64 0.318* 
Vitamin D (ng/mL) 44.81 ± 7.09 46.91 ± 9.16 0.474* 
IL-17 (pg/mL) 497.19 ± 148.34 515.57 ± 160.93 0.739* 
IL-1 (pg/mL) 69.81 ± 18.09 72.05 ± 19.62 0.739* 
IL-6 (pg/mL) 413.97 ± 95.09 425.75 ± 103.16 0.739* 
MEX SLEDAI 3.31 ± 2.30 3.69 ± 2.41 0.656* 
*Unpaired T Test; p = 0.05. 
 
The administration of Seluang fish oil was 
clinically able to show efficacy compared to placebo, 
which was assessed by the MEX SLEDAI score. 
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Significant results were also shown by vitamin D 
levels, which exhibited that Seluang fish oil was able 
to increase serum vitamin D levels compared with 
placebo. Increased levels of vitamin D in the group 
receiving Seluang fish oil was followed by a decrease 
in inflammatory markers, namely a significant 
reduction in levels of IL-1, IL-6 and IL-17, compared to 
the placebo group (Table 2). 
Table 2: Proinflammatory Cytokines and Vitamin D Levels 
Measurement Treatment Placebo P-value 
Mean ± SD Mean ± SD 
Vitamin D (ng/mL) 89.81 ± 7.11 47.12 ± 3.16 0.005* 
IL-17 (pg/mL) 245.31 ± 21.34 518.87 ± 65.33 0.001* 
IL-1 (pg/mL) 39.21 ± 7.09 72.65 ± 18.71 0.003* 
IL-6 (pg/mL) 213.47 ± 21.09 431.75 ± 34.46 0.001* 
MEX SLEDAI 1.31 ± 0.30 3.56 ± 1.41 0.006* 
*Unpaired T Test; p = 0.05. 
 
 
 
Discussion 
 
This study revealed the efficacy of Seluang 
fish oil as one of the newest therapeutic approaches 
to SLE. High level of vitamin D (cholecalciferol) is 
believed to be the biological plausibility of the efficacy 
of Seluang fish oil against SLE. Vitamin D is a sterol 
group compound which is important in the regulation 
related to the immune system [7]. 
Vitamin D is a signalling molecule that 
activates vitamin D receptors, which are part of 
intracellular receptors. Activation of the vitamin D 
receptor will suppress the regulator protein Nuclear 
Factor-Kappa Beta (NF-kB) gene expression so that 
NF-kB gene expression process does not occur and 
hence NF-kB protein is suppressed [8]. NF-kB is a 
transcription factor that plays a role in the expression 
of proinflammatory cytokine genes. NF-kB 
suppression causes a decrease in IL-2 gene 
expression and suppression of IL-2 cytokines. The 
occurrence of suppression of IL-2 causes a decrease 
in T lymphocyte cell proliferation, which will be 
followed by a decrease in lymphocyte cell 
proliferation. IL-2 is believed to play a major role in 
autoimmune disorders [9]. 
Proliferation suppression of lymphocyte cells 
causes suppression of auto-antibody production of 
cell components. This decrease in auto-antibody 
production will cause a decrease in cascade 
inflammatory activation and thus the pro-inflammatory 
cytokines, such as IL-1, IL-6 and IL-17 [10]. Activation 
of proinflammatory cytokines will cause oxidative 
stress in cells. Activation of oxidative stress causes 
caspase cascade activation, which will lead to cell 
death. Extensive cell death in the organ, causing 
damage to target organs, such as the kidneys, heart, 
lungs and blood vessels [11]. IL-6 is an inflammatory 
cytokine produced by various cells, such as 
monocytes, fibroblasts, endothelial cells and B and T 
lymphocyte cells. These cytokines regulate 
differentiation of lymphocyte B cells. Differentiation of 
B cells leads to the initiation of antibody production, Ig 
G. The increase in IL-6 certainly promotes the 
production of autoantibodies in SLE patients, which in 
turn worsens the clinical condition of SLE patients 
[12], [13]. IL-17 is a cytokine produced by lymphocyte 
T cells, a type of T-helper cell 17. IL-17 is believed to 
be an important inflammatory cytokine that plays a 
role in the process of organ destruction in SLE cases. 
Increased production of IL-2, will cause proliferation of 
T cells, including T-helper 17 cells [14], [15], [16]. 
Another study conducted on the SLE mice 
showed that vitamin D3 supplementation possessed 
good efficacy in suppressing the inflammatory 
process. Vitamin D3 suppressed the production of IL-
17, IL-23 and gamma interferon. Where an increase in 
IL-17, IL-23 and gamma interferon would lead to cell 
damage, especially the kidneys and blood vessels in 
mice [4, 10]. The above study certainly supported the 
results of this study, where high vitamin D contained 
in Seluang fish oil was believed to play a major role in 
the efficacy of Seluang fish oil in SLE cases. 
 In conclusion, Seluang fish oil possessed the 
efficacy of reducing the inflammatory response in SLE 
patients by increasing serum vitamin D levels. 
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